Novo Nordisk will slash the price of its blockbuster weight-loss drug Wegovy for cash-paying patients, after American rival Eli Lilly discounted some of its Zepbound injections last week. The Danish ...

Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

combined with injections of tirzepatide, a drug used increasingly for weight loss. “At first ... with brand names including Mounjaro and Zepbound. Aikman used a compounded tirzepatide, the ...

As chief scientific officer at Eli Lilly, he's already done it once with the company's weekly shot, Zepbound ... next great drug is not just about weight loss anymore, something more investors ...

Amneal Pharmaceuticals, Inc. offers strong growth prospects with undervalued stock, rising revenues, reduced debt, and key ...

Despite the current downward trend of NVO, it is a good stock to retain in one's portfolio for long-term gains due to strong ...

Oppenheimer Sets a $138 Price Target Based on Phase 2 Trial Results Viking Therapeutics stock surged 121% on February 27, 2024, on its Phase 2 VENTURE clinical trials results of 14.7% weight loss ...

REPORT Happy Friday! This weekend is daylight saving time, I’d tell you to change your clocks but I’m guessing most of us ...